Thank you for Subscribing to Life Science Review Weekly Brief
Startups and enterprises use bioinformatics solutions to generate a better feed, improve agricultural and livestock variations, and identify new microbes.
FREMONT, CA: Artificial intelligence, data analytics, and automation are all being used by the BioTech business to improve productivity. As a result, there has been an increase in consumer BioTech or BioTech goods aimed at customers rather than biopharma or healthcare companies. While most of the industry's attention is still on medicine, entrepreneurs are developing solutions for everything from food to materials to environmental monitoring. With startups and businesses alike generating quick diagnostic kits, repurposed medications, and vaccinations, the COVID-19 pandemic showed the BioTech industry's far-reaching effect.
Top BioTech Trends in 2021
Artificial Intelligence (AI)
BioTech firms may use AI to automate a variety of activities, allowing them to expand their operations. Biopharma businesses, for example, use AI to speed up the drug discovery process by evaluating biomarkers and scouring the scientific literature for new medicines. Image classification algorithms enable the quick detection of many qualities, such as cancer cells in medical scans and crop disease symptoms in leaf photos. In addition, deep learning is being used by companies to examine microbiomes, screen phenotypes, and generate quick diagnostics.
The ever-growing omics technologies and the integration of sensors and Internet of Things (IoT) devices have resulted in an unprecedented amount of data being available in biotechnology today. BioTech businesses may use big data and analytics technologies to tap into this abundance of data and drive innovation.
Startups and enterprises use bioinformatics solutions to generate a better feed, improve agricultural and livestock variations, and identify new microbes. It enables biopharmaceutical companies to more successfully recruit people for clinical trials.
Genetic engineering has progressed beyond randomly inserting foreign DNA into organisms to making precise alterations to genomes. The development of synthetic nucleases, and more recently CRISPR, as molecular scissors has boosted the effectiveness of gene editing. This paves the way for gene therapy to be used to treat genetic illnesses and other conditions, with genome editing techniques adding, replacing, or silencing certain genes. Targeted gene modification also allows for the creation of improved transgenic plants and animals.
Since gene editing and sequencing prices are decreasing, they are becoming more common in clinical practice. It enables precision medicine, which lets clinicians predict which treatment and prevention efforts will work best for a specific set of patients. Furthermore, it offers tailored treatment for a variety of disorders, including cancer. BioTech entrepreneurs employ precision medicine to uncover new medication targets, discover novel pharmaceuticals, provide gene treatments, and develop new drug delivery methods.